However, this was taken into account with the statistical methods utilised, revealing a strong trend in the reduction of LDL-C levels after the initiation of evolocumab treatment.
← all excerpts
A retrospective nationwide analysis of evolocumab use in Sweden and its effect on low-density lipoprotein cholesterol levels.
1
—
—